Opendata, web and dolomites

Spectra

Spectra- A novel diagnostic device to improve retinal imaging

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 Spectra project word cloud

Explore the words cloud of the Spectra project. It provides you a very rough idea of what is the project "Spectra" about.

unaware    markets    lacking    photograph    date    social    treatable    retineye    deployments    sight    spectra    medical    portability    eye    dr    suspected    security    diabetic    blindness    retinopathies    46    national    until    clinic    health    adaptable    expensive    economic    attendance    staff    qualified    patients    desp    uk    packages    providers    detect    macular    risk    missed    exist    diagnostic    burdens    portable    patient    highlights    age    benefitted    urgent    referrals    screening    standalone    software    irreversible    enabled    easier    fundus    lower    rarer    certified    degeneration    retinopathy    optometrists    sickness    glaucoma    stages    complemented    tremendous    street    retinal    pressure    throughput    analytical    integration    intelligence    severe    eminently    caring    diseases    diabetics    biomarkers    causes    50    time    footfall    cataracts    nhs    earlier    ocular    diabetes    greatest    reducing    teleopthalmology    records    english    damage    countries    benefits    preventable    monitor    reported    detects    models    tests    seamless   

Project "Spectra" data sheet

The following table provides information about the project.

Coordinator
HEALTH INTELLIGENCE LTD 

Organization address
address: MOSTON ROAD SAXON HOUSE
city: SANDBACH
postcode: CW11 3HL
website: www.health-intelligence.com

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country United Kingdom [UK]
 Project website https://health-intelligence.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2015
 Funding Scheme SME-1
 Starting year 2015
 Duration (year-month-day) from 2015-07-01   to  2015-12-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    HEALTH INTELLIGENCE LTD UK (SANDBACH) coordinator 50˙000.00

Map

 Project objective

Health Intelligence provide medical software as diagnostic medical devices. We have developed retinal (fundus) photograph analytical software - Spectra, complemented by the lower cost, standalone and portable Spectra Retineye. Spectra is one of only three software packages certified by the English National Diabetic Retinopathy (DR) Screening Programme. It has benefitted screening providers by seamless integration with patient records and ability to monitor over time. Providers reported improved throughput and attendance. Spectra highlights much more than just DR. In deployments to date, over 50% of urgent eye clinic referrals are for suspected non-diabetic retinopathies. Thus, Spectra detects reliable biomarkers for many conditions. The greatest causes of blindness (after cataracts) are glaucoma, age-related macular degeneration and DR. Spectra can detect early and treatable stages of these diseases, in particular low-pressure glaucoma missed by ocular pressure tests. New markets also exist for diabetic eye screening programmes (DESP) in countries lacking the resources of the UK NHS. Teleopthalmology (enabled by Spectra Retineye) could deliver these. Both Spectra and Spectra Retineye can deliver economic benefits: • Reducing need for expensive equipment and highly-qualified staff • Portability • Increased footfall in high-street optometrists from eye screening patients • Easier and lower cost of screening to patients • Reduced social security costs due to sight loss Spectra will deliver tremendous social benefits. Preventable, irreversible sight damage will become rarer, reducing sickness and caring burdens. Spectra Retineye, which is eminently adaptable to teleopthalmology will allow more delivery models. These will detect more problems earlier, including the 46% of diabetics who are unaware they have diabetes and thus risk severe sight loss and other health problems until they are identified.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "SPECTRA" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "SPECTRA" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

GACD (2019)

Global Alliance for Chronic Diseases Secretariat

Read More  

ISLET (2020)

Advancing Innovative Stem Cell-based Therapy for Diabetes in Europe

Read More  

DIAdIC (2019)

Evaluation of Dyadic Psychoeducational Interventions for People with Advanced Cancer and their Informal Caregivers (DIAdIC): An international randomized controlled trial

Read More